Warfarin metabolism during ethyl chlorophenoxyisobutyrate treatment.
D000328:Adult; D001779:Blood Coagulation Factors / Q000032:analysis; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000188:drug therapy; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008055:Lipids / Q000037:antagonists & inhibitors* / Q000097:blood*; D008297:Male; D014280:Triglycerides / Q000097:blood; D014859:Warfarin / Q000378:metabolism*
D001779:Blood Coagulation Factors; D000960:Hypolipidemic Agents; D008055:Lipids; D014280:Triglycerides; D014859:Warfarin; D002784:Cholesterol